Literature DB >> 6157747

Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity.

J R Ortaldo, W Phillips, K Wasserman, R B Herberman.   

Abstract

Human natural killer (NK) cell activity can be augmented by pretreatment with partially purified preparations of human interferon (IF). Studies have now been performed to determine the metabolic processes required for and involved in spontaneous NK activity and augmentation of cytotoxicity. A 4-hr 51Cr release cellular cytotoxicity assay was used to measure the NK activity, and peripheral blood leukocyte cells (PBL) were treated with: a) x-ray or mitomycin C; b) actinomycin D; or c) emetine, cycloheximide, pactamyhcin, or puromycin to assess the roles of DNA, RNA, and protein synthesis, respectively, in spontaneous NK activity and in boosting by IF. Prolonged incubation (18 hr) of PBL after blockage of synthesis of DNA almost completely abrogated NK activity; however, NK activity could be partially or totally restored to these populations by incubation of the effector cells for 1 hr at 37 degrees C with IF. Blockage of DNA synthesis for 1 hr had no effect on spontaneous NK activity or on boosting by IF. Inhibition of RNA synthesis also had no effect on spontaneous NK activity. Treatment of PBL with actinomycin before exposure to IF prevented boosting, but treatment with the RNA synthesis inhibitor after boosting with IF for 5 to 6 hr no longer had an appreciable effect on cytotoxicity. The effect of protein synthesis inhibitors on spontaneous NK activity was dependent on the inhibitor selected. Emetine and puromycin totally abrogated spontaneous NK activity at concentrations of inhibitor that blocked 3H-leucine incorporation 90% or more. In contrast, cycloheximide and pactamycin had only minimal effects on spontaneous NK activity but totally abrogated the boosting of IF.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157747

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Regulation of natural killer activity.

Authors:  J R Ortaldo
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Age distribution of circulating alpha-interferon.

Authors:  S Shiozawa; K Shiozawa; S Shimizu; Y Tanaka; I Morimoto; Y Kuroki; R Yoshihara; T Fujita
Journal:  Experientia       Date:  1989-08-15

Review 3.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

4.  Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans.

Authors:  G Fernandes; S Gupta
Journal:  J Clin Immunol       Date:  1981-07       Impact factor: 8.317

5.  Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.

Authors:  Jordan S Orange; Scott R Brodeur; Ashish Jain; Francisco A Bonilla; Lynda C Schneider; Roberto Kretschmer; Samuel Nurko; Wendy L Rasmussen; Julia R Köhler; Stephen E Gellis; Betsy M Ferguson; Jack L Strominger; Jonathan Zonana; Narayanaswamy Ramesh; Zuhair K Ballas; Raif S Geha
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

6.  A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients.

Authors:  S Shiozawa; K Chihara; K Shiozawa; T Fujita; H Ikegami; S Koyama; M Kurimoto
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

7.  Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.

Authors:  J P Flexman; G R Shellam
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

8.  The effect of radiotherapy on the natural killer (NK)-cell activity of cancer patients.

Authors:  K McGinnes; J Florence; R Penny
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

9.  In vitro boost of human NK activity by a triethylphosphine gold derivative.

Authors:  A S Russell; S Nakashima; C Miller
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

10.  Natural killer lytic-associated molecule plays a role in controlling tumor dissemination and metastasis.

Authors:  Richard G Hoover; Gail Gullickson; Jacki Kornbluth
Journal:  Front Immunol       Date:  2012-12-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.